Inventor · disambiguated record
Michael Gale
Also filed as: GALE JR MICHAEL · GALE JR MICHAEL J · GALE MICHAEL · GALE MICHAEL J
17 granted patents·6 pending applications·189 citations·filing 1997–2022
92Inventor score
Files withUNIV WASHINGTON8UNIV TEXAS5UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION4ATOMIC ENERGY OF CANADA LTD / ENERGIE ATOMIQUE DU CANADA LIMITEE2BAE SYS INF & ELECT SYS INTEG1
Top patents by PatentIndex Score
23 records- 0194US6326151B1Screening methods to identify agents that selectively inhibit hepatitis C virus replicationUNIV WASHINGTON·Filed 2000·Granted Dec 4, 2001·44 cites·22 claims
- 0291US6030785AScreening methods to identify agents that selectively inhibit hepatitis C virus replicationUNIV WASHINGTON·Filed 1998·Granted Feb 29, 2000·100 cites·12 claims
- 0390US9775894B2Methods and compositions for activation of innate immune responses through RIG-I like receptor signalingUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2014·Granted Oct 3, 2017·8 cites·12 claims
- 0489US12023375B2Methods and compositions for activation of innate immune responses through RIG-I like receptor signalingUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2022·Granted Jul 2, 2024·1 cites·17 claims
- 0589US7645732B2Treating hepatitis C virus infectionUNIV TEXAS·Filed 2007·Granted Jan 12, 2010·11 cites·27 claims
- 0688US10434164B2Methods and compositions for activation of innate immune responses through RIG-I like receptor signalingUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2017·Granted Oct 8, 2019·4 cites·20 claims
- 0785US11389532B2Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope proteinUNIV WASHINGTON·Filed 2018·Granted Jul 19, 2022·2 cites·24 claims
- 0883US11324817B2Methods and compositions for activation of innate immune responses through RIG-I like receptor signalingUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2019·Granted May 10, 2022·2 cites·26 claims
- 0978US12285482B2Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope proteinUNIV WASHINGTON·Filed 2022·Granted Apr 29, 2025·0 cites·20 claims
- 1076US10850979B2Hydrogen storage assemblyATOMIC ENERGY OF CANADA LTD / ENERGIE ATOMIQUE DU CANADA LIMITEE·Filed 2016·Granted Dec 1, 2020·2 cites·24 claims
- 1170US7148006B2Screening methods to identify agents that selectively inhibit hepatitis C virus replicationUNIV WASHINGTON·Filed 2001·Granted Dec 12, 2006·1 cites·27 claims
- 1267US8987189B2Treating hepatitis C virus infectionUNIV TEXAS·Filed 2013·Granted Mar 24, 2015·0 cites·20 claims
- 1366US11673802B2Hydrogen storage assemblyATOMIC ENERGY OF CANADA LTD / ENERGIE ATOMIQUE DU CANADA LIMITEE·Filed 2020·Granted Jun 13, 2023·0 cites·22 claims
- 1466US2010203013A1Treating Hepatitis C Virus InfectionUNIV TEXAS·Filed 2009·Application pending·0 cites
- 1557US2022241314A1Compositions and methods for treatment of hepatitis b virus infectionUNIV WASHINGTON·Filed 2022·Application pending·0 cites
- 1657US2022196658A1ANTI-VIRUS IgG3 BINDING ASSAY TO ASSESS VIRUS NEUTRALIZATION AND RELATED METHODSUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1755US2009248485A1Communications Propensity IndexMINOW GEORGE·Filed 2008·Application pending·0 cites
- 1849US7223787B2Prenylation inhibitors reduce host cell permissiveness to viral replicationUNIV TEXAS·Filed 2003·Granted May 29, 2007·0 cites·15 claims
- 1949US2021046168A1Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signalingUNIV WASHINGTON·Filed 2019·Application pending·0 cites
- 2043US7172862B2FBL2-specific agents as modulators of Flaviviridae RNA replicationUNIV TEXAS·Filed 2005·Granted Feb 6, 2007·0 cites·20 claims
- 2142US5894872AMotorcycle gasoline tank filling valveFiled 1997·Granted Apr 20, 1999·14 cites·5 claims
- 2239US11218513B2Information sharing with enhanced securityBAE SYS INF & ELECT SYS INTEG·Filed 2019·Granted Jan 4, 2022·0 cites·22 claims
- 2337US2013039887A1Methods of Identifying and Using Anti-Viral CompoundsKINETA INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Gale files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →